{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:14:00Z","timestamp":1789647240422,"version":"4.0.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.nucmedbio.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T07:30:54Z","timestamp":1632727854000},"page":"56-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Radiolabeling with [11C]HCN for Positron emission tomography"],"prefix":"10.1016","volume":"102-103","author":[{"given":"Yu-Peng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina J.","family":"Makaravage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Brugarolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nucmedbio.2021.09.002_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1021\/ar960068c","article-title":"Working against time: rapid radiotracer synthesis and imaging the human brain","volume":"30","author":"Fowler","year":"1997","journal-title":"Acc Chem Res"},{"issue":"16","key":"10.1016\/j.nucmedbio.2021.09.002_bb0010","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","article-title":"Positron emission tomography provides molecular imaging of biological processes","volume":"97","author":"Phelps","year":"2000","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd2290","article-title":"Molecular imaging in drug development","volume":"7","author":"Willmann","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"22","key":"10.1016\/j.nucmedbio.2021.09.002_bb0020","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1021\/jm5001858","article-title":"Positron emission tomography in CNS drug discovery and drug monitoring","volume":"57","author":"Piel","year":"2014","journal-title":"J Med Chem"},{"issue":"18","key":"10.1016\/j.nucmedbio.2021.09.002_bb0025","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2174\/0929867323666160418114826","article-title":"Considerations in the development of reversibly binding PET radioligands for brain imaging","volume":"23","author":"Victor","year":"2016","journal-title":"Curr Med Chem"},{"issue":"4","key":"10.1016\/j.nucmedbio.2021.09.002_bb0030","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1039\/C5CS00687B","article-title":"[18F]-group 13 fluoride derivatives as radiotracers for positron emission tomography","volume":"45","author":"Chansaenpak","year":"2016","journal-title":"Chem Soc Rev"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/acs.chemrev.5b00493","article-title":"18F-labeling of arenes and heteroarenes for applications in positron emission tomography","volume":"116","author":"Preshlock","year":"2016","journal-title":"Chem Rev"},{"issue":"15","key":"10.1016\/j.nucmedbio.2021.09.002_bb0040","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1039\/C6CS00492J","article-title":"Fluorine-18 labelled building blocks for PET tracer synthesis","volume":"46","author":"van der Born","year":"2017","journal-title":"Chem Soc Rev"},{"issue":"47","key":"10.1016\/j.nucmedbio.2021.09.002_bb0045","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1002\/anie.200800222","article-title":"Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography","volume":"47","author":"Miller","year":"2008","journal-title":"Angew Chem Int Ed"},{"issue":"9","key":"10.1016\/j.nucmedbio.2021.09.002_bb0050","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1071\/CH15406","article-title":"Total radiosynthesis: thinking outside \u2018the box\u2019","volume":"68","author":"Liang","year":"2015","journal-title":"Aust J Chem"},{"issue":"9","key":"10.1016\/j.nucmedbio.2021.09.002_bb0055","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/anie.201805501","article-title":"Chemistry for positron emission tomography: recent advances in 11C-, 18F-, 13N-, and 15O-labeling reactions","volume":"58","author":"Deng","year":"2019","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.114.145029","article-title":"Update on time-of-flight PET imaging","volume":"56","author":"Surti","year":"2015","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2967\/jnumed.116.184028","article-title":"Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care","volume":"59","author":"Cherry","year":"2018","journal-title":"J Nucl Med"},{"issue":"Supplement 1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0070","first-page":"34S","article-title":"Fifty years of radiopharmaceuticals","volume":"48","author":"Brugarolas","year":"2020","journal-title":"J Nucl Med Technol"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jlcr.3258","article-title":"Development of carbon-11 labelled PET tracers\u2014radiochemical and technological challenges in a historic perspective","volume":"58","author":"Antoni","year":"2015","journal-title":"J Label Compd Radiopharm"},{"issue":"1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/nuka-2016-0007","article-title":"Synthesis of C-methionine through gas phase iodination using synthra MeI synthesis module","volume":"61","author":"Kilian","year":"2016","journal-title":"Nukleonika"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40336-017-0223-1","article-title":"New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals","volume":"5","author":"Dahl","year":"2017","journal-title":"Clin Transl Imaging"},{"issue":"50","key":"10.1016\/j.nucmedbio.2021.09.002_bb0090","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1039\/c3cc42236d","article-title":"11CO2 fixation: a renaissance in PET radiochemistry","volume":"49","author":"Rotstein","year":"2013","journal-title":"Chem Commun"},{"issue":"4","key":"10.1016\/j.nucmedbio.2021.09.002_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jlcr.3150","article-title":"Transition metal mediated [11C]carbonylation reactions: recent advances and applications","volume":"57","author":"Kealey","year":"2014","journal-title":"J Label Compd Radiopharm"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jlcr.3262","article-title":"[11C]Carbon monoxide in labeling chemistry and positron emission tomography tracer development: scope and limitations","volume":"58","author":"Rahman","year":"2015","journal-title":"J Label Compd Radiopharm"},{"issue":"17","key":"10.1016\/j.nucmedbio.2021.09.002_bb0105","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1039\/C6CS00310A","article-title":"11C=O bonds made easily for positron emission tomography radiopharmaceuticals","volume":"45","author":"Rotstein","year":"2016","journal-title":"Chem Soc Rev"},{"issue":"1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41181-019-0073-4","article-title":"[11C]Carbon monoxide: advances in production and application to PET radiotracer development over the past 15 years","volume":"4","author":"Taddei","year":"2019","journal-title":"EJNMMI Radiopharmacy Chem."},{"issue":"13","key":"10.1016\/j.nucmedbio.2021.09.002_bb0115","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/jlcr.3633","article-title":"New trends and applications in carboxylation for isotope chemistry","volume":"61","author":"Bragg","year":"2018","journal-title":"J Label Compd Radiopharm"},{"issue":"13","key":"10.1016\/j.nucmedbio.2021.09.002_bb0120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/jlcr.3645","article-title":"Recent developments in carbonylation chemistry using [13C]CO, [11C]CO, and [14C]CO","volume":"61","author":"Nielsen","year":"2018","journal-title":"J Label Compd Radiopharm"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jlcr.3596","article-title":"Recent progress in [11C]carbon dioxide ([11C]CO2) and [11C]carbon monoxide ([11C]CO) chemistry","volume":"61","author":"Taddei","year":"2018","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0130","series-title":"Adv. heterocycl. chem","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.aihch.2019.11.005","article-title":"Chapter four - The chemistry of labeling heterocycles with carbon-11 or fluorine-18 for biomedical imaging","volume":"Vol. 132","author":"Lu","year":"2020"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.nucmedbio.2020.04.007","article-title":"[11C]phosgene: synthesis and application for development of PET radiotracers","volume":"92","author":"Fukumura","year":"2021","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nucmedbio.2020.02.005","article-title":"The development of 11C-carbonylation chemistry: a systematic view","volume":"92","author":"Eriksson","year":"2021","journal-title":"Nucl Med Biol"},{"issue":"18","key":"10.1016\/j.nucmedbio.2021.09.002_bb0145","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1039\/C8CS00499D","article-title":"Boron reagents for divergent radiochemistry","volume":"47","author":"Wilson","year":"2018","journal-title":"Chem Soc Rev"},{"issue":"14","key":"10.1016\/j.nucmedbio.2021.09.002_bb0150","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jlcr.3630","article-title":"New trends and applications in cyanation isotope chemistry","volume":"61","author":"Derdau","year":"2018","journal-title":"J Label Compd Radiopharm"},{"issue":"12","key":"10.1016\/j.nucmedbio.2021.09.002_bb0155","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/0022-1902(64)80156-1","article-title":"Reactions of atomic carbon with \u03c0-bonded inorganic molecules","volume":"26","author":"Dubrin","year":"1964","journal-title":"J Inorg Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1524\/ract.1966.6.1.32","article-title":"Reactions of energetic carbon atoms with nitrogen molecules [1]","volume":"6","author":"Ache","year":"1966","journal-title":"Radiochim. Acta"},{"issue":"12","key":"10.1016\/j.nucmedbio.2021.09.002_bb0165","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0020-708X(71)90137-2","article-title":"The preparation of cyanide-11C for use in the synthesis of organic radiopharmaceuticals II","volume":"22","author":"Finn","year":"1971","journal-title":"Int J Appl Radiat Isot"},{"issue":"11","key":"10.1016\/j.nucmedbio.2021.09.002_bb0170","first-page":"864","article-title":"Production of carrier-free H11CN for medical use and radiopharmaceutical syntheses. IX","volume":"14","author":"Christman","year":"1973","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.nucmedbio.2021.09.002_bb0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0020-708X(75)90057-5","article-title":"The production of ultra high activity 11C-labeled hydrogen cyanide, carbon dioxide, carbon monoxide and methane via the 14N(p, \u03b1)11C reaction (XV)","volume":"26","author":"Christman","year":"1975","journal-title":"Int J Appl Radiat Isot"},{"issue":"1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0020-708X(84)90127-3","article-title":"Production of no-carrier-added 11C-carbon disulfide and 11C-hydrogen cyanide by microwave discharge","volume":"35","author":"Niisawa","year":"1984","journal-title":"Int J Appl Radiat Isot"},{"issue":"8","key":"10.1016\/j.nucmedbio.2021.09.002_bb0185","first-page":"474","article-title":"Organic radiopharmaceuticals labeled with isotopes of short half-life I: 11C-1-dopamine hydrochloride","volume":"11","author":"Christman","year":"1970","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.nucmedbio.2021.09.002_bb0190","first-page":"867","article-title":"Synthesis and preliminary evaluation in animals of carrier-free 11C-1-dopamine hydrochloride: X","volume":"14","author":"Fowler","year":"1973","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1021\/jm00248a025","article-title":"Radiopharmaceuticals. 12. New rapid synthesis of carbon-11-labeled norepinephrine hydrochloride","volume":"17","author":"Fowler","year":"1974","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0200","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1021\/jm00225a002","article-title":"Radiopharmaceuticals. 16. Halogenated dopamine analogs. Synthesis and radiolabeling of 6-iododopamine and tissue distribution studies in animals","volume":"19","author":"Fowler","year":"1976","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0205","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0037-1620708","article-title":"Preparation and scintigraphic evaluation of carbon-11-labeled 2-N-phenethylaminoalkanenitriles","volume":"17","author":"Winstead","year":"1978","journal-title":"Nuklearmedizin"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0883-2889(87)90003-7","article-title":"Optimization of [11C]HCN production and no-carrier-added [1-11C]amino acid synthesis. international journal of radiation applications and instrumentation. part a","volume":"38","author":"Iwata","year":"1987","journal-title":"Appl Radiat Isot"},{"issue":"12","key":"10.1016\/j.nucmedbio.2021.09.002_bb0215","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0883-2889(90)90205-U","article-title":"An alternative synthesis of DL-[1-11C]Alanine from [11C]HCN","volume":"41","author":"Takahashi","year":"1990","journal-title":"Int J Radiat Appl Instrum Part A"},{"issue":"9","key":"10.1016\/j.nucmedbio.2021.09.002_bb0220","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0969-8043(95)00146-5","article-title":"On-column preparation of 1-aminocyclopentane-1-[11C]carboxylic acid","volume":"46","author":"Iwata","year":"1995","journal-title":"Appl Radiat Isot"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0225","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2967\/jnumed.112.113100","article-title":"Radiolabeled amino acids for oncologic imaging","volume":"54","author":"Huang","year":"2013","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3891\/acta.chem.scand.44-0178","article-title":"Enzymatic-synthesis of carboxy-C-11-labeled L-tyrosine, L-DOPA, L-tryptophan and 5-hydroxy-L-tryptophan","volume":"44","author":"Bjurling","year":"1990","journal-title":"Acta Chem Scand"},{"issue":"4","key":"10.1016\/j.nucmedbio.2021.09.002_bb0235","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/jlcr.2580280409","article-title":"Synthesis of 1- and 3\u201311C-labelled L-lactic acid using multi-enzyme catalysis","volume":"28","author":"Bjurling","year":"1990","journal-title":"J Label Compd Radiopharm"},{"issue":"12","key":"10.1016\/j.nucmedbio.2021.09.002_bb0240","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.apradiso.2006.05.013","article-title":"Automated no-carrier-added synthesis of [1-11C]-labeled d- and l-enantiomers of lactic acid","volume":"64","author":"Drandarov","year":"2006","journal-title":"Appl Radiat Isot"},{"issue":"5","key":"10.1016\/j.nucmedbio.2021.09.002_bb0245","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0883-2889(90)90006-3","article-title":"[11C]octopamine synthesis using [11C]cyanide: chemical and enzymatic approaches for the [11C]cyanohydrin synthesis","volume":"41","author":"Maeda","year":"1990","journal-title":"Int J Radiat Appl Instrum Part A"},{"issue":"1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0969-8051(02)00349-9","article-title":"Synthesis of no-carrier-added C-11 labeled D- and L-enantiomers of phenylalanine and tyrosine for comparative PET studies","volume":"30","author":"Studenov","year":"2003","journal-title":"Nucl Med Biol"},{"issue":"10","key":"10.1016\/j.nucmedbio.2021.09.002_bb0255","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/ml500285t","article-title":"Radiosynthesis of 11C-levetiracetam: a potential marker for PET imaging of SV2A expression","volume":"5","author":"Cai","year":"2014","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0260","first-page":"662","article-title":"Proceedings of the 25th annual meeting","volume":"19","year":"1978","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlcr.2580160102","article-title":"Abstracts. Second international symposium on radiopharmaceuticals chemistry","volume":"16","year":"1979","journal-title":"J Label Compd Radiopharm"},{"issue":"1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0008-6215(00)84787-4","article-title":"A new synthesis of 2-deoxy-d-arabino-hexose","volume":"74","author":"Shiue","year":"1979","journal-title":"Carbohydr Res"},{"issue":"9","key":"10.1016\/j.nucmedbio.2021.09.002_bb0275","first-page":"800","article-title":"A synthesis of 2-deoxy-D-[1-11C]Glucose for regional metabolic studies: concise communication","volume":"22","author":"MacGregor","year":"1981","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jlcr.2580200310","article-title":"Quality control procedures in the preparation of 2-deoxy-D-[1-11C] glucose radiopharmaceutical","volume":"20","author":"Vora","year":"1983","journal-title":"J Label Compd Radiopharm"},{"issue":"8","key":"10.1016\/j.nucmedbio.2021.09.002_bb0285","first-page":"739","article-title":"The unit operations approach to the applied to the synthesis of [1-11C]2-deoxy-d-glucose for routine clinical applications","volume":"23","author":"Padgett","year":"1982","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.nucmedbio.2021.09.002_bb0290","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1002\/cber.19721051129","article-title":"Notiz \u00fcber die schnelle synthese von [3-11C]\u03b2-alanin","volume":"105","author":"Elias","year":"1972","journal-title":"Chem Ber"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0047-0740(77)90138-3","article-title":"Synthesis and distribution kinetics in animals of [\u03b1-11C] 3,4-dimethoxyphenethylamine","volume":"4","author":"Mestelan","year":"1977","journal-title":"Int J Nucl Med Biol"},{"issue":"11","key":"10.1016\/j.nucmedbio.2021.09.002_bb0300","first-page":"481","article-title":"11C-2-deoxy-d-glucose: synthesis and preliminary comparison with 11C-d-glucose as a tracer for cerebral energy metabolism in PET studies","volume":"10","author":"Stone-Elander","year":"1985","journal-title":"Eur J Nucl Med"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0305","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jlcr.2580220704","article-title":"Routine production of 2-deoxy-D-[1-11C]glucose : an alternative","volume":"22","author":"van Haver","year":"1985","journal-title":"J Label Compd Radiopharm"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0310","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00252479","article-title":"Relationship of molecular structure to in vivo distribution of carbon-11-labeled compounds","volume":"5","author":"Winstead","year":"1980","journal-title":"Eur J Nucl Med"},{"issue":"10","key":"10.1016\/j.nucmedbio.2021.09.002_bb0315","first-page":"1186","article-title":"Synthesis and biodistribution of no-carrier-added [1-11C]Putrescine","volume":"26","author":"McPherson","year":"1985","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.nucmedbio.2021.09.002_bb0320","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/jlcr.2580270913","article-title":"Synthesis of L-[5-11C]ornithine","volume":"27","author":"Ding","year":"1989","journal-title":"J Label Compd Radiopharm"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0325","first-page":"1107","article-title":"Synthesis and radiopharmaceutical preparation of (Ethylenediamine) (1-Carbon-11-Malonate) Platinum(II) for PET studies","volume":"29","author":"De Spiegeleer","year":"1988","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.nucmedbio.2021.09.002_bb0330","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/jlcr.2580331102","article-title":"Preparation of [11C]diethyl oxalate and [11C]oxalic acid and demonstration of their use in the synthesis of [11C]-2,3-dihydroxyquinoxaline","volume":"33","author":"Thorell","year":"1993","journal-title":"J Label Compd Radiopharm"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0335","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0883-2889(90)90079-V","article-title":"Synthesis of 1\u201311C-labeled fatty acid from [11C]HCN","volume":"41","author":"Takahashi","year":"1990","journal-title":"Int J Radiat Appl Instrum Part A"},{"issue":"11","key":"10.1016\/j.nucmedbio.2021.09.002_bb0340","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0883-2889(91)90010-X","article-title":"11C-labeling of busulphan","volume":"42","author":"Hassan","year":"1991","journal-title":"Int J Radiat Appl Instrum Part A"},{"issue":"4","key":"10.1016\/j.nucmedbio.2021.09.002_bb0345","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/jlcr.2580340410","article-title":"Difunctional two-carbon molecules derived from [11C]cyanide","volume":"34","author":"Thorell","year":"1994","journal-title":"J Label Compd Radiopharm"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0350","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jlcr.544","article-title":"Novel synthesis of [1-11C]\u03b3-vinyl-\u03b3-aminobutyric acid ([1\u201311C]GVG) for pharmacokinetic studies of addiction treatment","volume":"45","author":"Zhang","year":"2002","journal-title":"J Label Compd Radiopharm"},{"issue":"46","key":"10.1016\/j.nucmedbio.2021.09.002_bb0355","doi-asserted-by":"crossref","first-page":"11235","DOI":"10.1039\/C5OB01654A","article-title":"An efficient and practical synthesis of [2-11C]indole via superfast nucleophilic [11C]cyanation and RANEY\u00ae nickel catalyzed reductive cyclization","volume":"13","author":"Lee","year":"2015","journal-title":"Org Biomol Chem"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0360","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00726-014-1883-z","article-title":"Investigation of SN2 [11C]cyanation for base-sensitive substrates: an improved radiosynthesis of L-[5-11C]-glutamine","volume":"47","author":"Gleede","year":"2015","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0365","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0969-8051(97)00032-2","article-title":"Synthesis of L-2,4-Diamino[4-11C]butyric acid and its use in some in vitro and in vivo tumour models","volume":"24","author":"Antoni","year":"1997","journal-title":"Nucl Med Biol"},{"issue":"4","key":"10.1016\/j.nucmedbio.2021.09.002_bb0370","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jlcr.454","article-title":"Enzyme catalysed synthesis of L-[4-11C]aspartate and L-[5-11C]glutamate","volume":"44","author":"Antoni","year":"2001","journal-title":"J Label Compd Radiopharm"},{"issue":"8","key":"10.1016\/j.nucmedbio.2021.09.002_bb0375","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jlcr.1894","article-title":"Radiosynthesis of C-11 labeled auxin (3-indolyl[1-11C]acetic acid) and its derivatives from gramine","volume":"54","author":"Reid","year":"2011","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0380","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.apradiso.2014.05.017","article-title":"Radiosynthesis of 3-indolyl[1-11C]acetic acid for phyto-PET-imaging: An improved production procedure and formulation method","volume":"91","author":"Xu","year":"2014","journal-title":"Appl Radiat Isot"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0385","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tetlet.2014.12.014","article-title":"Tetraethylene glycol promoted two-step, one-pot rapid synthesis of indole-3-[1-11C]acetic acid","volume":"56","author":"Lee","year":"2015","journal-title":"Tetrahedron Lett"},{"issue":"8","key":"10.1016\/j.nucmedbio.2021.09.002_bb0390","first-page":"748","article-title":"Carboxyl-labeled 11C-1-aminocyclopentanecarboxylic acid, a potential agent for cancer detection","volume":"17","author":"Hayes","year":"1976","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0395","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0020-708X(78)90142-4","article-title":"Synthesis and purification of 11C-carboxyl-labeled amino acids","volume":"29","author":"Hayes","year":"1978","journal-title":"Int J Appl Radiat Isot"},{"issue":"4","key":"10.1016\/j.nucmedbio.2021.09.002_bb0400","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0020-708X(85)90084-5","article-title":"Routine production of H11CN and [11C]-1-aminocyclopentanecarboxylic acid","volume":"36","author":"Sambre","year":"1985","journal-title":"Int J Appl Radiat Isot"},{"issue":"5","key":"10.1016\/j.nucmedbio.2021.09.002_bb0405","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0020-708X(81)90093-4","article-title":"Preparation and preliminary tissue studies of optically active 11C-D- and L-phenylalanine","volume":"32","author":"Casey","year":"1981","journal-title":"Int J Appl Radiat Isot"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0410","first-page":"515","article-title":"L-[1-11C]Leucine: routine synthesis by enzymatic resolution","volume":"24","author":"Barrio","year":"1983","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0415","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0047-0740(84)90001-9","article-title":"Synthesis and quality assurance of [11C]alpha-aminoisobutyric acid (AIB), a potential radiotracer for imaging and amino acid transport studies in normal and malignant tissues","volume":"11","author":"Schmall","year":"1984","journal-title":"Int J Nucl Med Biol"},{"issue":"9","key":"10.1016\/j.nucmedbio.2021.09.002_bb0420","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0883-2889(87)90254-1","article-title":"11C-labelled glycine: synthesis and preliminary report on its use in the investigation of intracranial tumours using positron emission tomography","volume":"38","author":"Johnstr\u00f6m","year":"1987","journal-title":"Int J Radiat Appl Instrum Part A"},{"issue":"8","key":"10.1016\/j.nucmedbio.2021.09.002_bb0425","first-page":"887","article-title":"Enzymatic synthesis of [1-11C]Pyruvic acid, l-[1-11C]Lactic acid and l-[1-11C]Alanine via dl-[1-11C]Alanine","volume":"25","author":"Ropchan","year":"1984","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.nucmedbio.2021.09.002_bb0430","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0883-2889(91)90192-4","article-title":"A remote control process for the routine synthesis of branched chain [1-11C]\u03b1 amino acids","volume":"42","author":"Fissekis","year":"1991","journal-title":"Int J Radiat Appl Instrum Part A"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0435","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jlcr.2580220210","article-title":"The syntheses of 1-[11C]-D-glucose and related compounds for the measurement of brain glucose metabolism","volume":"22","author":"Shiue","year":"1985","journal-title":"J Label Compd Radiopharm"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0440","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jlcr.2580250302","article-title":"Enantioselective synthesis of 11C-labeled phenylethanolamine","volume":"25","author":"Maeda","year":"1988","journal-title":"J Label Compd Radiopharm"},{"issue":"1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlcr.2580270102","article-title":"A convenient synthesis of D-[1-11C]glucopyranose and D-[1-11C]galactopyranose using diborane","volume":"27","author":"Tada","year":"1989","journal-title":"J Label Compd Radiopharm"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0450","first-page":"195","article-title":"Automated synthesis of radiopharmaceuticals for PET - an apparatus for 1-C-11 labelled aldoses","volume":"16","author":"Nishimura","year":"1994","journal-title":"J Autom Chem"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0455","first-page":"371","article-title":"High-yielding automated convergent synthesis of no-carrier-added C-11-carbonyl -labeled amino acids using the strecker reaction","volume":"28","author":"Xing","year":"2017","journal-title":"Synlett"},{"issue":"27","key":"10.1016\/j.nucmedbio.2021.09.002_bb0460","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1039\/C6CC00895J","article-title":"[11C]Ascorbic and [11C]dehydroascorbic acid, an endogenous redox pair for sensing reactive oxygen species using positron emission tomography","volume":"52","author":"Carroll","year":"2016","journal-title":"Chem Commun"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0465","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1039\/c39900000370","article-title":"Novel solid-state support for rapid synthesis of radiopharmaceuticals labelled with [11C]-cyanide","volume":"5","author":"Somawardhana","year":"1990","journal-title":"J Chem Soc Chem Commun"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0470","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0883-2889(91)90161-S","article-title":"Solid state support for the synthesis of [1\u221211C]-putrescine","volume":"42","author":"Somawardhana","year":"1991","journal-title":"Int J Radiat Appl Instrum Part A"},{"issue":"5","key":"10.1016\/j.nucmedbio.2021.09.002_bb0475","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jlcr.2580270510","article-title":"Synthesis of \u03b3-amino[4-11C]butyric acid (GABA)","volume":"27","author":"Antoni","year":"1989","journal-title":"J Label Compd Radiopharm"},{"issue":"13","key":"10.1016\/j.nucmedbio.2021.09.002_bb0480","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jlcr.517","article-title":"Synthesis of [4-11C]amino acids via ring-opening of aziridine-2-carboxylates","volume":"44","author":"Gillings","year":"2001","journal-title":"J Label Compd Radiopharm"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0485","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0020-708X(78)90081-9","article-title":"Synthesis and preliminary scintigraphic evaluation of in vivo distribution of 11C-hydroxyurea\/isohydroxyurea and 11C-cyanate","volume":"29","author":"Winstead","year":"1978","journal-title":"Int J Appl Radiat Isot"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0490","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0020-708X(83)90082-0","article-title":"Preparation of 11C-urea from no-carrier-added 11C-cyanide","volume":"34","author":"Emran","year":"1983","journal-title":"Int J Appl Radiat Isot"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0495","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0020-708X(85)90229-7","article-title":"Use of 11C as a tracer for studying the synthesis of [11C]urea from [11C]cyanide","volume":"36","author":"Boothe","year":"1985","journal-title":"Int J Appl Radiat Isot"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0500","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02061029","article-title":"Use of liquid chromatography for separation and determination of carrier species associated with the synthesis of no carrier-added 11C-labelled compounds determination of the specific activity of [11C]urea","volume":"91","author":"Emran","year":"1985","journal-title":"J Radioanal Nucl Chem"},{"issue":"9","key":"10.1016\/j.nucmedbio.2021.09.002_bb0505","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0020-708X(85)90046-8","article-title":"Optimized production of high specific activity [11C]urea","volume":"36","author":"Emran","year":"1985","journal-title":"Int J Appl Radiat Isot"},{"issue":"10","key":"10.1016\/j.nucmedbio.2021.09.002_bb0510","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0883-2889(86)90043-2","article-title":"Use of 11C as a tracer for studying the synthesis of radiolabelled compounds\u2014II: 2-[11C]-5,5-diphenylhydantoin from [11C]cyanide. international journal of radiation applications and instrumentation. part a","volume":"37","author":"Emran","year":"1986","journal-title":"Appl Radiat Isot"},{"issue":"10","key":"10.1016\/j.nucmedbio.2021.09.002_bb0515","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3891\/acta.chem.scand.47-0974","article-title":"Synthesis of C-11 cyanogen-bromide and (C-13)-cyanogen bromide, useful electrophilic labeling precursors","volume":"47","author":"Westerberg","year":"1993","journal-title":"Acta Chem Scand"},{"issue":"4","key":"10.1016\/j.nucmedbio.2021.09.002_bb0520","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0969-8043(96)00303-X","article-title":"On-line production of [11C]cyanogen bromide","volume":"48","author":"Westerberg","year":"1997","journal-title":"Appl Radiat Isot"},{"issue":"8","key":"10.1016\/j.nucmedbio.2021.09.002_bb0525","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jlcr.2580340802","article-title":"[11C]cyanogen bromide in the synthesis of 1,3-di(2-tolyl)-[11C]guanidine","volume":"34","author":"Westerberg","year":"1994","journal-title":"J Label Compd Radiopharm"},{"issue":"11","key":"10.1016\/j.nucmedbio.2021.09.002_bb0530","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/acsmedchemlett.0c00479","article-title":"Fully automated radiosynthesis of [11C]Guanidines for cardiac PET imaging","volume":"11","author":"Zhao","year":"2020","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0535","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0969-8051(94)00091-W","article-title":"Labelling of polysaccharides using [11C]cyanogen bromide. In vivo and in vitro evaluation of 11C-hyaluronan uptake kinetics","volume":"22","author":"Westerberg","year":"1995","journal-title":"Nucl Med Biol"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0540","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0883-2889(86)90163-2","article-title":"Synthesis of no-carrier-added 11C-labelled methylamine","volume":"37","author":"Amano","year":"1986","journal-title":"Int J Radiat Appl Instrum Part A"},{"issue":"27","key":"10.1016\/j.nucmedbio.2021.09.002_bb0545","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/S0040-4039(00)92821-1","article-title":"Exchange between labelled cyanide and the nitrile function of acetonitrile","volume":"21","author":"Jay","year":"1980","journal-title":"Tetrahedron Lett"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0550","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0883-2889(86)90149-8","article-title":"Carbon-11 labeled dialkylketones: synthesis of 9-[11C]heptadecan-9-one","volume":"37","author":"Kothari","year":"1986","journal-title":"Int J Radiat Appl Instrum Part A"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0555","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.nucmedbio.2015.02.001","article-title":"Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing","volume":"42","author":"Johnstr\u00f6m","year":"2015","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0560","first-page":"1054","volume":"23","author":"Balatoni","year":"1986","journal-title":"J Label Compd Radiopharm"},{"issue":"12","key":"10.1016\/j.nucmedbio.2021.09.002_bb0565","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/jlcr.2580271210","article-title":"Synthesis of 11C-labeled aromatics using aryl chromium tricarbonyl intermediates","volume":"27","author":"Balatoni","year":"1989","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0570","first-page":"144","volume":"30","author":"Andersson","year":"1991","journal-title":"J Label Compd Radiopharm"},{"issue":"11","key":"10.1016\/j.nucmedbio.2021.09.002_bb0575","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1039\/P19940001395","article-title":"Transition metal-mediated reactions using C-11 cyanide in synthesis of C-11 labeled aromatic-compounds","volume":"1","author":"Andersson","year":"1994","journal-title":"J Chem Soc Perkin Trans"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0580","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0969-8043(94)90251-8","article-title":"Synthesis of 11C-labelled benzamide compounds as potential tracers for poly(ADP-ribose) synthetase","volume":"45","author":"Andersson","year":"1994","journal-title":"Appl Radiat Isot"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0585","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1021\/ja512115s","article-title":"Virtually instantaneous, room-temperature [11C]-cyanation using biaryl phosphine Pd(0) complexes","volume":"137","author":"Lee","year":"2015","journal-title":"J Am Chem Soc"},{"issue":"21","key":"10.1016\/j.nucmedbio.2021.09.002_bb0590","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1021\/jacs.7b02761","article-title":"Direct 11CN-labeling of unprotected peptides via palladium-mediated sequential cross-coupling reactions","volume":"139","author":"Zhao","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"41","key":"10.1016\/j.nucmedbio.2021.09.002_bb0595","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1039\/C8OB02049C","article-title":"Palladium(II)-mediated rapid 11C-cyanation of (hetero)arylborons","volume":"16","author":"Zhang","year":"2018","journal-title":"Org Biomol Chem"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0600","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1099-1344(199806)41:6<567::AID-JLCR96>3.0.CO;2-8","article-title":"Synthesis of a 11C-labelled derivative of the N-methyl-D-aspartate receptor antagonist MK-801","volume":"41","author":"Andersson","year":"1998","journal-title":"J Label Compd Radiopharm"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0605","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0969-8051(98)00091-2","article-title":"Radiosynthesis and autoradiographic evaluation of [11C]NAD-299, a radioligand for visualization of the 5-HT1A receptor","volume":"26","author":"Sandell","year":"1999","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0969-8051(01)00272-4","article-title":"PET-examination and metabolite evaluation in monkey of [11C]NAD-299, a radioligand for visualisation of the 5-HT1A receptor","volume":"29","author":"Sandell","year":"2002","journal-title":"Nucl Med Biol"},{"issue":"18","key":"10.1016\/j.nucmedbio.2021.09.002_bb0615","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1021\/jm800329z","article-title":"Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid Subtype-1 (CB1) receptors","volume":"51","author":"Donohue","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0620","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neuroimage.2013.09.043","article-title":"In vitro and in vivo evaluation of 11C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors","volume":"84","author":"Tsujikawa","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0625","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuropharm.2015.03.002","article-title":"A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates","volume":"101","author":"Hjorth","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.nucmedbio.2021.09.002_bb0630","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nucmedbio.2008.11.010","article-title":"Synthesis and PET studies of [11C-cyano]letrozole (Femara), an aromatase inhibitor drug","volume":"36","author":"Kil","year":"2009","journal-title":"Nucl Med Biol"},{"issue":"17","key":"10.1016\/j.nucmedbio.2021.09.002_bb0635","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1016\/j.bmcl.2009.07.055","article-title":"Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. part 3: radiosynthesis and in vivo studies","volume":"19","author":"Bennacef","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0640","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1021\/jm901858n","article-title":"Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons","volume":"53","author":"Liu","year":"2010","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.nucmedbio.2021.09.002_bb0645","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00259-012-2205-x","article-title":"Synthesis and characterization in monkey of [11C]SP203 as a radioligand for imaging brain metabotropic glutamate 5 receptors","volume":"39","author":"Sim\u00e9on","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0650","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1177\/0271678X16668891","article-title":"Comparison of two PET radioligands, [11C]FPEB and [11C]SP203, for quantification of metabotropic glutamate receptor 5 in human brain","volume":"37","author":"Lohith","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"10.1016\/j.nucmedbio.2021.09.002_bb0655","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.nucmedbio.2012.12.012","article-title":"Palladium mediated 11C-cyanation and characterization in the non-human primate brain of the novel mGluR5 radioligand [11C]AZD9272","volume":"40","author":"Andersson","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0660","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuropharm.2018.03.039","article-title":"The metabotropic glutamate receptor 5 radioligand [11C]AZD9272 identifies unique binding sites in primate brain","volume":"135","author":"Varn\u00e4s","year":"2018","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0665","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/acschemneuro.9b00680","article-title":"Synthesis, biodistribution, and radiation dosimetry of a novel mGluR5 radioligand: 18F-AZD9272","volume":"11","author":"Nag","year":"2020","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107809","article-title":"The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans","volume":"162","author":"Varn\u00e4s","year":"2020","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.nucmedbio.2021.09.002_bb0675","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2967\/jnumed.112.109512","article-title":"Synthesis and evaluation of 11C-LY2795050 as a \u03ba-opioid receptor antagonist radiotracer for PET imaging","volume":"54","author":"Zheng","year":"2013","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0680","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2967\/jnumed.114.138701","article-title":"An improved antagonist radiotracer for the \u03ba-opioid receptor: synthesis and characterization of 11C-LY2459989","volume":"55","author":"Zheng","year":"2014","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2021.09.002_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlcr.1461","article-title":"Radiosynthesis of [11C]ximelagatran via palladium catalyzed [11C]cyanation","volume":"51","author":"Airaksinen","year":"2008","journal-title":"J Label Compd Radiopharm"},{"issue":"7","key":"10.1016\/j.nucmedbio.2021.09.002_bb0690","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1039\/b009850g","article-title":"Total synthesis and radiolabelling of an efficient rt-PA inhibitor: [11C] (Z,Z)-BABCH. A first route to [11C] labelled amidines","volume":"1","author":"Sim\u00e9on","year":"2001","journal-title":"J Chem Soc Perkin Trans"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0700","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0969-8043(96)00299-0","article-title":"[11C]copper(I) cyanide: a new radioactive precursor for 11C-cyanation and functionalization of haloarenes","volume":"48","author":"Ponchant","year":"1997","journal-title":"Appl Radiat Isot"},{"issue":"9","key":"10.1016\/j.nucmedbio.2021.09.002_bb0705","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0223-5234(97)88917-9","article-title":"Radiosynthesis of [tetrazoyl-11C]irbesartan, a non-peptidic angiotensin II antagonist","volume":"32","author":"Ponchant","year":"1997","journal-title":"Eur J Med Chem"},{"issue":"49","key":"10.1016\/j.nucmedbio.2021.09.002_bb0710","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1039\/C7CC02886E","article-title":"[11C]Cyanation of arylboronic acids in aqueous solutions","volume":"53","author":"Ma","year":"2017","journal-title":"Chem Commun"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0715","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1021\/acs.orglett.8b00242","article-title":"Copper(II)-mediated [11C]Cyanation of arylboronic acids and arylstannanes","volume":"20","author":"Makaravage","year":"2018","journal-title":"Org Lett"},{"issue":"12","key":"10.1016\/j.nucmedbio.2021.09.002_bb0720","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1021\/acsmedchemlett.8b00460","article-title":"Radiosynthesis of [11C]LY2795050 for preclinical and clinical PET imaging using Cu(II)-mediated cyanation","volume":"9","author":"Yang","year":"2018","journal-title":"ACS Med Chem Lett"},{"issue":"9","key":"10.1016\/j.nucmedbio.2021.09.002_bb0725","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jlcr.1100","article-title":"Synthesis of a mGluR5 antagonist using [11C]copper(I) cyanide","volume":"49","author":"Mathews","year":"2006","journal-title":"J Label Compd Radiopharm"},{"issue":"16","key":"10.1016\/j.nucmedbio.2021.09.002_bb0730","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1021\/jm400772t","article-title":"Synthesis and evaluation of novel radioligands for positron emission tomography imaging of the Orexin-2 receptor","volume":"56","author":"Oi","year":"2013","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.nucmedbio.2021.09.002_bb0735","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00259-021-05269-4","article-title":"Synthesis and preclinical evaluation of [11C]MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain","volume":"48","author":"Obokata","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.nucmedbio.2021.09.002_bb0740","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0883-2889(91)90162-T","article-title":"Radiopharmaceutical for differential diagnosis of tuberculoma: synthesis of 2\u2212[11C]cyano-isonicotinic acid hydrazide. international journal of radiation applications and instrumentation. part a","volume":"42","author":"Somawardhana","year":"1991","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2021.09.002_bb9000","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1002\/ejoc.202100651","article-title":"[11C]HCN Radiochemistry: Recent Progress and Future Perspectives","volume":"33","author":"Xu","year":"2021","journal-title":"European Journal of Organic Chemistry"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805121005059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805121005059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:30:17Z","timestamp":1760848217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805121005059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":148,"alternative-id":["S0969805121005059"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2021.09.002","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiolabeling with [11C]HCN for Positron emission tomography","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}